首页 | 本学科首页   官方微博 | 高级检索  
     


Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome
Affiliation:1. Department of Haematology, Royal North Shore Hospital, St Leonards, New South Wales, Australia;2. Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia;1. Augustana College, Rock Island, Ill;2. Mercy Hospital & Medical Center, Chicago, Ill;1. Department of Neurosurgery, Shaare Zedek Medical Center, Jerusalem, Israel;2. Department of Neurosurgery, Rabin Medical Center, Petah Tiqva, Israel;3. Neurophysiology Unit, Rabin Medical Center, Petah Tiqva, Israel;4. Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel;1. ICREA at IFAE, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain;2. DESY, Notkestraße 85, 22607 Hamburg, Germany;1. Department of Neurosurgery, Otto-von-Guericke University, Magdeburg, Germany;2. Department of Neurosurgery, Nordstadt Hospital, Hanover, Germany;3. Department of Pathology, Nordstadt Hospital, Hanover, Germany
Abstract:
Keywords:Defibrotide  Diffuse Large B cell Lymphoma  Hepatotoxicity  Veno-occlusive disease  Vincristine
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号